Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Asset Writedowns and Impairment (2016 - 2025)

Cryo Cell International (CCEL) has disclosed Asset Writedowns and Impairment for 16 consecutive years, with -$780197.0 as the latest value for Q4 2025.

  • On a quarterly basis, Asset Writedowns and Impairment changed N/A to -$780197.0 in Q4 2025 year-over-year; TTM through Aug 2025 was $780197.0, a 33.7% decrease, with the full-year FY2024 number at $308000.0, down 64.55% from a year prior.
  • Asset Writedowns and Impairment was -$780197.0 for Q4 2025 at Cryo Cell International, down from $413611.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $1.2 million in Q4 2021 to a low of -$780197.0 in Q4 2025.
  • A 5-year average of $202947.4 and a median of $176542.5 in 2021 define the central range for Asset Writedowns and Impairment.
  • Peak YoY movement for Asset Writedowns and Impairment: skyrocketed 1533.03% in 2022, then plummeted 179.34% in 2023.
  • Cryo Cell International's Asset Writedowns and Impairment stood at $1.2 million in 2021, then crashed by 79.87% to $234452.0 in 2022, then surged by 270.56% to $868795.0 in 2023, then plummeted by 97.79% to $19240.0 in 2024, then tumbled by 4155.08% to -$780197.0 in 2025.
  • Per Business Quant, the three most recent readings for CCEL's Asset Writedowns and Impairment are -$780197.0 (Q4 2025), $413611.0 (Q3 2025), and $95379.0 (Q2 2025).